Clinical trial assesses the efficacy of suvorexant in reducing delirium in older adults
A study by Juntendo University researchers assessed whether suvorexant, a sleep-promoting medication, could reduce delirium in older adults. Published in JAMA Network Open, the double-blind, placebo-controlled trial found suvorexant showed a trend towards reducing delirium, particularly hyperactive and mixed types, though the difference was not statistically significant.
Reference News
Clinical trial assesses the efficacy of suvorexant in reducing delirium in older adults
A study by Juntendo University researchers assessed whether suvorexant, a sleep-promoting medication, could reduce delirium in older adults. Published in JAMA Network Open, the double-blind, placebo-controlled trial found suvorexant showed a trend towards reducing delirium, particularly hyperactive and mixed types, though the difference was not statistically significant.